Get started
Author

Marleen H. C. Bakkus

Observed names: Bakkus, M, Bakkus, M., Bakkus, M. H., Bakkus, Marleen, M Bakkus, M H Bakkus, M. Bakkus, M. H. Bakkus, M. H. C. Bakkus, MARLEEN BAKKUS, MH Bakkus, Marleen Bakkus, Marleen Bâkkus
Observed institutions: Université Libre de Bruxelles, Vrije Universiteit Brussel, Janssen (Belgium), Netherlands Organisation for Applied Scientific Research, Utrecht University, Heidelberg University, Erasmus MC, Karolinska Institutet, Assistance Publique – Hôpitaux de Paris, European Society for Blood and Marrow Transplantation, Hôpital Lyon Sud, Amgen (United Kingdom), Universitair Ziekenhuis Brussel, European Society for Blood and Marrow Transplantation, Bicêtre Hospital, Academisch Ziekenhuis Rotterdam, Erasmus University Rotterdam, Leipzig University, KU Leuven
ORCID: 0000-0002-0863-3369
Observed ORCID: 0000-0002-0863-3369
OpenAlex ID: A5081603184
Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
1998 · Hélène Cavé, Jutte van der Werff ten Bosch, et al. · New England Journal of Medicine · 768
PDF
Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation
1992 · MH Bakkus, C Heirman, et al. · Blood · 314
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
1994 · VéRonique Flamand, Thierry Sornasse, et al. · European Journal of Immunology · 291
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3
2007 · A. De Becker, P. Van Hummelen, et al. · Haematologica · 230
PDF
Genes encoding tumor-specific antigens are expressed in human myeloma cells.
1999 · N van Baren, F Brasseur, et al. · PubMed · 195
Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor
1998 · Marc G. Jacquemin, Benoı̂t G. Desqueper, et al. · Blood · 161
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
2013 · E Clappier, M-F Auclerc, et al. · Leukemia · 152
Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell
1994 · Marleen H. C. Bakkus, Ivan Van Riet, et al. · British Journal of Haematology · 138
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor
2000 · Marc Jacquemin, Abdellah Benhida, et al. · Blood · 123
Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model
2004 · E Menu, R Kooijman, et al. · British Journal of Cancer · 115
PDF
ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia
1997 · H Cavé, V Cacheux, et al. · Leukemia · 104
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951
2015 · E Clappier, N Grardel, et al. · Leukemia · 100
CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules
1997 · LE Van den Hove, SW Van Gool, et al. · Leukemia · 100
Interleukin-1 and Interleukin-6 in Psoriasis
1990 · Errol P. Prens, Klazina Benne, et al. · Journal of Investigative Dermatology · 82
Post‐transplantation tumour load in bone marrow, as assessed by quantitative ASO‐PCR, is a prognostic parameter in multiple myeloma
2004 · Marleen H. C. Bakkus, Yasmina Bouko, et al. · British Journal of Haematology · 81
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results
2013 · Nicole Dastugue, Stefan Suciu, et al. · Blood · 79
In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells
2000 · Asosingh, K., Günthert, U., et al. · PubMed · 74
Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
1995 · A B Geldhof, G Raes, et al. · PubMed · 72
Quantitation of Vasopressin mRNA and Oxytocin mRNA in Hypothalamic Nuclei by Solution Hybridization Assays
1986 · J. Peter H. Burbach, Hubert H. M. Van Tol, et al. · Journal of Neurochemistry · 58
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study
2007 · J.-H. Bourhis, Y. Bouko, et al. · Haematologica · 56
PDF
CD40L‐Induced IL‐12 Production is Further Enhanced by the Th2 Cytokines IL‐4 and IL‐13
2001 · D. M. A. Bullens, A. Kasran, et al. · Scandinavian Journal of Immunology · 52
PDF
Upregulation of matrix metalloproteinase‐9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells
2002 · Els Van Valckenborgh, Marleen Bakkus, et al. · International Journal of Cancer · 49
PDF
Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation
1999 · Jeroen E. J. Guikema, Edo Vellenga, et al. · British Journal of Haematology · 48
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
2017 · Claire Schwab, Karin Nebral, et al. · Blood Advances · 38
PDF
Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia
2016 · Farzaneh Ghazavi, Barbara De Moerloose, et al. · Oncotarget · 35
PDF
Works count: 111
Citation count: 4,009
H-index: 28
I10-index: 46
Year
Topic
Type